---
title: "Expanded approval for Navitor TAVR system – CE Mark in Europe"
date: "2025-09-05T12:14:25.000Z"
publishedDate: "5 septembre 2025"
summary: "Originally CE marked in 2021 for limited to high-risk patients only, .Abbott has now received CE mark approval for its Navitor transcatheter aortic valve replacement (TAVR) system to treat low- and intermediate-risk patients with symptomatic, severe aortic stenosis. The post Expanded approval for Navitor TAVR system &#8211; CE Mark in&nbsp;Europe appeared first on MedTech Intelligence ."
importance: ""
sourceUrl: "https://medtechintelligence.com/news_article/expanded-approval-for-navitor-tavr-system-ce-mark-in-europe/"
tags: ["France", "Actualité", "MedTech Intelligence"]
permalink: "/papers/2025-09-05-expanded-approval-for-navitor-tavr-system-ce-mark-in-europe"
imageUrl: "https://medtechintelligence.com/wp-content/uploads/2025/09/Abbott-navitor.png.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://medtechintelligence.com/news_article/expanded-approval-for-navitor-tavr-system-ce-mark-in-europe/"
---

![Expanded approval for Navitor TAVR system – CE Mark in Europe](https://medtechintelligence.com/wp-content/uploads/2025/09/Abbott-navitor.png.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://medtechintelligence.com/news_article/expanded-approval-for-navitor-tavr-system-ce-mark-in-europe/*

## L’essentiel

Originally CE marked in 2021 for limited to high-risk patients only, .Abbott has now received CE mark approval for its Navitor transcatheter aortic valve replacement (TAVR) system to treat low- and intermediate-risk patients with symptomatic, severe aortic stenosis. The post Expanded approval for Navitor TAVR system &#8211; CE Mark in&nbsp;Europe appeared first on MedTech Intelligence .

## Lien source

https://medtechintelligence.com/news_article/expanded-approval-for-navitor-tavr-system-ce-mark-in-europe/
